Development of sealants will speed up move away from conventional sutures
New innovations in the medical adhesives sector will accelerate the move away from the use of sutures and staples.
Innovation of sealants as a drug delivery mechanism will be crucial to accelerating the shift that is occurring away from conventional sutures, strips and staples.
That is according to research by Frost & Sullivan, which claims that the need for reduced operating and postoperative times is facilitating a shift towards the use of adhesives and sealants.
However, it added that the development of new methods for applying tissue sealant and using it to administer drugs will not only speed up the shift away from sutures and staples, but also expand the scope for adhesive applications.
Looking at the North American market for medical adhesives and sealants alone, the analyst estimated that it was worth $85.2 million (£53.8 million) in 2011 - a figure that is expected to reach $182.6 million (£115.4 million)by 2018 thanks to a healthy compound annual growth rate of 11.5 per cent.
It attributes growth in sales to application-based products and the use of modified polymers, as well as a rising number of surgical procedures taking place.
Raghu Tantry, senior industry analyst at Frost & Sullivan, said: "While cardio surgery is expected to contribute significantly to the internal medicine sector's revenue growth, the well established dental adhesives and sealants segment will grow at a relatively slower pace."
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance